Zobrazeno 1 - 10
of 66
pro vyhledávání: '"David R. Okada"'
Autor:
Bibin Varghese, Tarek Zghaib, Eric Xie, Stefan L. Zimmerman, Nisha A. Gilotra, David R. Okada, Joao A.C. Lima, Jonathan Chrispin
Publikováno v:
American Heart Journal Plus, Vol 22, Iss , Pp 100209- (2022)
Background: Right ventricular (RV) dysfunction and late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) are associated with ventricular arrhythmias (VA) and mortality in cardiac sarcoidosis (CS). However, image resolution lim
Externí odkaz:
https://doaj.org/article/99d3195af97f4b189dcdc70cb6571016
Autor:
David R. Okada, John Smith, Arsalan Derakhshan, Zain Gowani, Stefan L. Zimmerman, Satish Misra, Ronald D. Berger, Hugh Calkins, Harikrishna Tandri, Jonathan Chrispin
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 23, Iss , Pp - (2019)
Background: Abnormalities on cardiac imaging (cardiac magnetic resonance imaging [CMR] or positron emission tomography [PET]), left ventricular ejection fraction (LVEF), and electrophysiology study (EPS) all predict ventricular arrhythmias (VA) in pa
Externí odkaz:
https://doaj.org/article/a571c026596b4d2987f9136407f0f1f1
Autor:
Mária Kohári, David R. Okada, Larraitz Gaztanaga, Erica Zado, Francis E. Marchlinski, David J. Callans, Yuchi Han
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 9, Iss C, Pp 89-94 (2015)
Background: Detection of concurrent diastolic dysfunction (DD) may be beneficial in patients with persistent and longstanding persistent atrial fibrillation (AF). The role of transthoracic echocardiography (TTE) in assessing DD in patients with AF ha
Externí odkaz:
https://doaj.org/article/4654756489a7467e8c47ec3509bec912
Autor:
Alison L. Wand, Noelle Pavlovic, Chloe Duvall, Natalie S. Rosen, Jessica Chasler, Jan M. Griffin, David R. Okada, Artrish Jefferson, Jonathan Chrispin, Harikrishna Tandri, Stephen C. Mathai, Michelle Sharp, Edward S. Chen, Edward K. Kasper, Allison G. Hays, Nisha A. Gilotra
Publikováno v:
The American Journal of Cardiology. 177:108-115
Cardiac sarcoidosis (CS) is an important cause of cardiomyopathy. The trajectory of left ventricular ejection fraction (LVEF) in patients with CS undergoing treatment remains unclear. Patients with CS who were treated with corticosteroids and who und
Autor:
CHLOE DUVALL, NOELLE PAVLOVIC, NATALIE S. ROSEN, ALISON L. WAND, JAN M. GRIFFIN, DAVID R. OKADA, HARIKRISHNA TANDRI, EDWARD K. KASPER, MICHELLE SHARP, EDWARD S. CHEN, JONATHAN CHRISPIN, NISHA A. GILOTRA
Publikováno v:
Journal of Cardiac Failure.
Autor:
Ashish Correa, Dhrubajyoti Bandyopadhyay, Birendra Amgai, David R. Okada, Kam Ho, Neel Patel, Bharat Narasimhan, Chayakrit Krittanawong, Rushil Shah, Davendra Mehta, Kirtipal Bhatia, Lingling Wu
Publikováno v:
JACC: Clinical Electrophysiology. 7:1087-1095
Objectives This study sought to identify electrocardiographic (ECG) and clinical predictors of sudden cardiac arrest (SCA) in sarcoidosis. Background Sudden cardiac death (SCD) is the leading cause of death in cardiac sarcoidosis (CS) and may be the
Publikováno v:
Arrhythmia & Electrophysiology Review, Vol 9, Iss 4, Pp 182-188 (2020)
Arrhythmia & Electrophysiology Review
Arrhythmia & Electrophysiology Review
Sarcoidosis is an inflammatory granulomatous disease that can affect any organ. Up to one-quarter of patients with systemic sarcoidosis may have evidence of cardiac involvement. The clinical manifestations of cardiac sarcoidosis (CS) include heart bl
Publikováno v:
Annals of Nuclear Medicine. 34:87-93
Cardiac sarcoidosis is a granulomatous disease that may affect any organ, including the heart. Diagnosis of cardiac sarcoidosis is challenging, given the varied and non-specific clinical presentation and limited sensitivity and specificity of availab
Autor:
Eric Xie, David R. Okada, Jonathan Chrispin, Adityo Prakosa, Nisha A. Gilotra, Natalia A. Trayanova, Katherine C. Wu, Usama A. Daimee, Konstantinos N. Aronis
Publikováno v:
Pacing Clin Electrophysiol
Background: Patients with cardiac sarcoidosis (CS) are at increased risk of life-threatening ventricular arrhythmias (VA). Current approaches to risk stratification have limited predictive value. Objectives: To assess the utility of spatial dispersio
Autor:
Alison L. Wand, David R. Okada, Harikrishna Tandri, Lilja Solnes, Edward K. Kasper, Elie Saad, Nisha A. Gilotra, Edward H. Chen, Jan M. Griffin, Jonathan Chrispin
Publikováno v:
JACC: Cardiovascular Imaging. 13:1280-1282
Corticosteroids are the mainstay of therapy for cardiac sarcoidosis (CS) ([1][1]); however, long-term exposure may be associated with numerous side effects. Although cardiac 18-fluorodoxyglucose position emission tomography (FDG-PET) is useful in tai